Stevanato Group (STVN) Prices 32M Share IPO at $21/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Stevanato Group Announces Pricing of Initial Public Offering
July 15, 2021 6:41 PM EDTExpects to begin trading on NYSE on July 16, 2021 under ticker symbol STVN
PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (the Company), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its initial public offering of 32,000,000 of its ordinary shares at a price of $21 per share.
The shares are expected to begin trading on the New York Stock Exchange on July 16, 2021, under the ticker symbol STVN. The offering is expected to close on July 20, 2021, subject to customary closing... More
